Skip to main content
Lu Lin, MD, Neurology, Houston, TX

LuLinMD, PhD

Neurology Houston, TX

Epilepsy, Neurophysiology

Physician

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lin's full profile

Already have an account?

  • Office

    7200 Cambridge St
    Ste 9A
    Houston, TX 77030
    Phone+1 713-798-2273
    Fax+1 713-798-7561

Education & Training

  • Brigham and Women’s Hospital/Children’s Hospital/Harvard Medical School
    Brigham and Women’s Hospital/Children’s Hospital/Harvard Medical SchoolFellowship, Epilepsy, 2017 - 2018
  • Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical School
    Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 2016 - 2017
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Neurology, 2012 - 2016
  • Beijing Medical University
    Beijing Medical UniversityClass of 2003

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2026
  • MA State Medical License
    MA State Medical License 2016 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • PA State Medical License
    PA State Medical License 2016 - 2018
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology
  • American Board of Psychiatry and Neurology Epilepsy

Publications & Presentations

PubMed

Press Mentions

  • COVID-19-Associated Seizures May Be Common, Linked to Higher Risk of Death
    COVID-19-Associated Seizures May Be Common, Linked to Higher Risk of DeathApril 16th, 2021
  • Study of COX-2 Inhibitors Could Lead to New Class of Stroke Drugs
    Study of COX-2 Inhibitors Could Lead to New Class of Stroke DrugsOctober 4th, 2011